Holocene Advisors
GILD icon

Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Holocene Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-641,700
Closed -$49.4M – 712
2020
Q2 		$49.4M Buy
+641,700
New +$49.2M 0.43% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Holocene Advisors's GILD Position: Q1 2026 in Review

Holocene Advisors reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $217M and leaving 2,611,826 shares worth $364M. The position accounts for 0.88% of the portfolio, ranked #22.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 10 quarters since. The position peaked at $511M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Holocene Advisors held 2,611,826 shares of Gilead Sciences worth $364M as of Q1 2026.
  • Holocene Advisors sold 1,552,612 Gilead Sciences shares in Q1 2026, an estimated $217M.
  • Gilead Sciences made up 0.88% of Holocene Advisors's portfolio in Q1 2026, its #22 holding.
  • Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 10 quarters since.
  • Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.